Human Osteoprotegerin/TNFRSF11B DuoSet ELISA DY805 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman Osteoprotegerin/TNFRSF11B DuoSet ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY805
ReactivityHuman
Detection TargetOsteoprotegerin/TNFRSF11B
Detection Range62.50 - 4000 pg/mL
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameTNF receptor superfamily member 11b
NCBI Gene AliasesOCIF, OPG, PDB5, TR1

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Reciprocal macrophage-MSC crosstalk drives immunomodulatory and regenerative phenotypes in a mineralized collagen scaffoldbioRxivMarch 16, 2026Vasiliki Kolliopoulos, Maxwell Polanek, Hashni E. Vidana Vidana Gamage, Melisande Wong Yan Wong Yan Ling, Aleczandria Tiffany, Erik R. Nelson, Kara L. Spiller, Brendan A.C. Harleyimmunomodulatory factors IDO1, PGE2, IL-6, and CCL22 were quantified via their respective ELISAs (OPG – DY805, IL6 – DY206, IDO - DY6030, PGE2 – KGE004B, CCL22 - DY336, R&D Systems, Minneapolis, MN, USA) (Figure

(2) Serum Dkk-1 Is Associated with Pain Intensity, Flare-Ups, and Bone Mineral Density in Non-Obese Patients with Knee Osteoarthritis: A Single-Center, Cross-Sectional StudyInternational Journal of Molecular SciencesFebruary 26, 2026Timea-Csilla Nagy-Finna, Árpád Sólyom, János Székely, Pál-István Kikeli, Erika-Lídia Szövérfi, Hunor Lukács, Anna-Lilla Faragó, Emőke Horváth, Horațiu Popoviciu, Előd Ernő Nagyconcentrations of OPG (R&D Systems, Minneapolis, MN, USA, Human Osteoprotegerin/TNFRSF11B Duoset ELISA, DY805), RANKL (R&D Systems, Human TRANCE/RANKL/TNFSF11 Duoset ELISA, DY626), sclerostin (R&D Systems, Human SOST/Sclerostin Duoset ELISA

(3) A synbiotic medical food improves gut barrier function, reduces immune responses, and inhibits osteoclast activity in models of postmenopausal bone loss aligned with clinical outcomesJournal of Functional FoodsJanuary 26, 2026Ryan S. Green, Tyler Roy, Daniela Diaz-Infante Morales, Claire Morrow, Ryan Neilson, Eric M. Schott, Mark R. Charbonneau, Alicia E. Ballok, Katherine J. Motyl, Gerardo V. Toledo(CAT# 431501); and R&D systems, Minneapolis, MN: IFN-γ (CAT# DY285B), CXCL1 (CAT# DY275), OPG (CAT# DY805), IL-10 (CAT# DY217B)). 2.5. PBMC LPS challenge and SBD111 treatments Frozen PBMCs from the healthy

(4) Crosstalk between endothelial cells and osteoblasts stimulates ALP via Notch signaling and RANKL/OPG ratio independently of Notch signaling in vitroCell Mol Biol LettOctober 2, 2025Katharina Wirsig, Nina Bürger, Anne BernhardtHuman TRANCE/RANKL/TNFS11 DuoSet ELISA no. DY626; Human Osteoprotegerin/TNFRSF11B DuoSet ELISA no. DY805 (both R&D Systems), and Human VEGF Standard TMB ELISA Development Kit no. 900-T10 (PeproTech) using

(5) Effect of hyperbaric oxygen therapy (HBO) on osteoblasts of elderly patients on calcification and osteoprotegerinJournal of orthopaedicsSeptember 1, 2025Oezel L, Schneppendahl J, Grassmann JP, Flender P, Dreyer S, Grotheer V.added in duplicate to ELISA wells following the manufacturer's instructions (DuoSet ELISA, R&D Systems, DY805). Optical density was measured using a Victor X3 Multilabel Reader (PerkinElmer). 2.14 RANKL mRNA expression analysis

(6) Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid CancerbioRxiv : the preprint server for biologyJuly 14, 2025Bagheri-Yarmand R, Pagnotti GM, Kidd JL, Ramirez DA, Trivedi T, Guerra L, Wang Z, Cruz LM, Moehle JM, Jebaraj YS, et al.

(7) Osteoprotegerin and its ligands RANKL and TRAIL in falciparum, vivax, and knowlesi malariaiScienceJune 20, 2025Arya Sheela Nair, John Woodford, Jessica Loughland, Dean Andrew, Kim Piera, Fiona Amante, Timothy William, Matthew J. Grigg, James S. McCarthy, Nicholas M. Anstey, et al.commercial assays,Critical commercial assays ,, Human Osteoprotegerin/TNFRSF11B DuoSet ELISA,R&D Systems,DY805 RANKL ELISA kit,Biomedica Diagnostics,BI-20462 TRAIL ELISA kit,R&D Systems,DTRL00 Ang 2 Quantikine

(8) Connecting the dots: (RANKL+) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancerTranslational Lung Cancer ResearchMarch 31, 2025Anita J. W. M. Brouns, Iris J. Robbesom-van den Berge, Sophie M. Ernst, Christi M. J. Steendam, Wouter W. Woud, Liang Wu, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Marjolein van DrielELISA (R&D systems, Minneapolis, MN, USA; DY626) and human OPG/TNFRSF11B Duoset ELISA (R&D systems, DY805) were performed according to the manufacturer protocol. Thawed plasma samples were centrifuged for 5

(9) Multi-study feasibility analysis on a composite biomarker of inflammatory resilience to quantify the effects of energy restriction on low-grade inflammation in overweight and obese individualsEur J NutrMarch 4, 2025Mark C. Dessing, Tim J. van den Broek, Femke P. M. Hoevenaars, Willem J. van den Brink, Milena Rundle, Gary Frost, Lydia Afman, Suzan Wopereis(R&D Systems, DY724), P-selectin (R&D Systems, DY137), sICAM-1 (R&D Systems, DY720), sVCAM-1 (R&D Systems, DY805), SAA (R&D Systems, DY3019), CRP (R&D Systems, DY1707), and total PAI-1 (R&D Systems, DY9387). For each

(10) Crosstalk between macrophages and mesenchymal stem cells shape patterns of osteogenesis and immunomodulation in mineralized collagen scaffoldsBioactive materialsFebruary 1, 2025Kolliopoulos V, Polanek M, Wong Yan Ling M, Tiffany A, Spiller KL, Harley BAC.secreted by hMSCs, and immunomodulatory factors IDO, PGE2, and IL-6 via their respective ELISAs (OPG – DY805, IL-6 – DY206, PGE2 – KGE004B, IDO - DY6030, R&D Systems, Minneapolis, MN, USA) (Fig. 2) in order to

(11) Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcomaScientific reportsJanuary 13, 2025Haskell A, Pan S, Reese R, Powers A, Lopez MG, Lomeli S, Story C, Benton J, Blazier JC, Kaunas R, et al.

(12) SARS-CoV-2 ORF8 drives osteoclastogenesis in preexisting immune-mediated inflammatory diseasesJCI insightDecember 20, 2024Melano I, Azamor T, Caetano CC, Meyer NM, Onwubueke C, Visperas A, Familiar-Macedo D, Salem GM, Soos BL, Calabrese CM, et al.

(13) Non-classical monocyte levels correlate negatively with HIV-associated cerebral small vessel disease and cognitive performanceFrontiers in Cellular and Infection MicrobiologyOctober 23, 2024Meera V. Singh, Md Nasir Uddin, Mae Covacevich Vidalle, Karli R. Sutton, Zachary D. Boodoo, Angelique N. Peterson, Alicia Tyrell, Madalina E. Tivarus, Henry Z. Wang, Bogachan Sahin, et al.(# DY383, R and D systems, MN, USA), CD163 (# DY1607, R and D systems, MN, USA), Osteoprotegerin (# DY805, R and D systems, MN, USA) and lipoprotein associated phospholipase A2 (LpPLA2) (# ab235643, Abcam,

(14) Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery DiseaseBiomoleculesSeptember 4, 2024Bate KA, Genetzakis E, Vescovi J, Gray MP, Celermajer DS, McGuire HM, Grieve SM, Vernon ST, Cartland SP, Yang JY, et al.Human TRAIL/TNFSF10 Quantikine ELISA kit, #DTLR00, Minneapolis, MN, USA), OPG (R&D Systems Human Osteoprotegerin/TNFRSF11B, #DY805, Minneapolis, MN, USA), and IL-18 (Abcam Human IL-18 SimpleStep ELISA Kit, #ab215539, Melbourne, VIC,

(15) Bone Regenerative Effect of Injectable Hypoxia Preconditioned Serum-Fibrin (HPS-F) in an Ex Vivo Bone Defect ModelInternational journal of molecular sciencesMay 13, 2024Jiang J, Röper L, Fuchs F, Hanschen M, Failer S, Alageel S, Cong X, Dornseifer U, Schilling AF, Machens HG, et al.Human Trance/ RANK L/ TNFSF11 DuoSet (Catalog #: DY626); Osteoprotegerin/TNFRSF11B DuoSet (Catalog #: DY805); Human BMP-2 DuoSet (Catalog #: DY355); Human BMP-7 DuoSet (Catalog #: DY354); Human Osteocalcin DuoSet

(16) Preliminary Study on Pulse Wave Changes in Patients with Inflammatory Arthropathies Treated with bDMARDsJournal of clinical medicineMay 2, 2024Gasparotto M, Di Pierro G, Toffoli B, Grillo A, Bressan M, Fiorentin M, Di Luozzo L, Fischetti F, Zen M, Fabris B, et al.(OPG) and the receptor activator of nuclear factor-kB ligand (RANKL). OPG was measured with the R&D #DY805 ELISA kit and RANKL was measured with the R&D #DY626 ELISA kit (R&D System, Minneapolis, MN, USA). Each

(17) Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D(3) and Respond to 24R,25-dihydroxyvitamin D(3) via a Mechanism Dependent on Estrogen Receptor LevelsCancersApril 24, 2024Dennis CD, Dillon JT, Patel PH, Cohen DJ, Halquist MS, Pearcy AC, Boyan BD, Schwartz Z.treatment, conditioned media were collected and assayed for OPG (R&D Systems, Minneapolis, MN, CAT #DY805) and RANKL (PeproTech, Cranbury, NJ, USA, CAT #900-K142). Total DNA content was measured in the cell

(18) Different Methods to Modify the Hydrophilicity of Titanium Implants with Biomimetic Surface Topography to Induce Variable Responses in Bone Marrow Stromal CellsBiomimetics (Basel)April 10, 2024Thomas W. Jacobs, Jonathan T. Dillon, David J. Cohen, Barbara D. Boyan, Zvi Schwartzharvested conditioned media. Osteocalcin (DY1419-05, OCN), osteopontin (DY1433, OPN), osteoprotegerin (DY805, OPG), vascular endothelial growth factor 165 (DY293B-05, VEGF), interleukin-6 (DY206, IL-6), and interleukin-10

(19) Evaluating osteogenic effects associated with the incorporation of ascorbic acid in mineralized collagen scaffoldsJournal of Biomedical Materials Research Part AMarch 1, 2024Marley J. Dewey, Kyle B. Timmer, Ashley Blystone, Crislyn Lu, Brendan A. C. HarleyOsteoprotegerin Release Osteoprotegerin (OPG) release was measured using a Human OPG DuoSet ELISA (R&D Systems DY805 Lot# P246532, MN, USA) using a previously developed protocol [21, 22, 29, 30]. Seeded scaffolds (n=6)

(20) Cellular response of advanced triple cultures of human osteocytes, osteoblasts and osteoclasts to high sulfated hyaluronan (sHA3)Materials Today BioFebruary 22, 2024Katharina Wirsig, Jana Bacova, Richard F. Richter, Vera Hintze, Anne BernhardtDY1419-05; Human TRANCE/RANKL/TNFS11 DuoSet ELISA # DY626; Human Osteoprotegerin/TNFRSF11B DuoSet ELISA # DY805; Human SOST/Sclerostin DuoSet ELISA # DY1406; all R&D Systems). After detection and development, absorbance

Be the First to Write a Review!

Human Osteoprotegerin/TNFRSF11B DuoSet ELISA

Human Osteoprotegerin/TNFRSF11B DuoSet ELISA from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (146)

Reviews

Human Osteoprotegerin/TNFRSF11B DuoSet ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map